Selank: The Tuftsin Analogue and Its Role in Neuroprotection
15th Jul 2026

What You Need to Know About Selank
- Researchers frequently investigate Selank to understand how adding three specific amino acids to the natural immune peptide tuftsin helps protect the molecule from rapid enzymatic breakdown.
- In plain English, Selank acts like a gentle regulator for brain chemistry by slowing down the destruction of natural calming messengers called enkephalins.
- Published studies observe that this peptide interacts with GABA receptors and alters the expression of dozens of genes linked to nerve cell communication.
- Preclinical models show that Selank increases Measured levels of Brain-Derived Neurotrophic Factor (BDNF) in the hippocampus, a key region for memory and cellular recovery.
How Selank Supports Calm Focus and Neural Recovery
Selank is a synthetic seven-amino-acid peptide built from tuftsin, a natural immune fragment, with three extra amino acids added to keep it stable longer. In laboratory models, it calms overactive stress signalling while boosting the growth factors that help brain cells recover and maintain sharp focus.
To understand how Selank works, it helps to look at its parent molecule, tuftsin. Tuftsin is a tiny four-amino-acid chain that naturally splits off from an immune protein called immunoglobulin G. On its own, tuftsin breaks down in minutes when exposed to natural enzymes. Chemists solved this rapid breakdown by attaching a three-amino-acid tail—Proline-Glycine-Proline, often shortened to PGP—onto the end of the chain. That small structural addition gives Selank a much longer working window in published studies, allowing researchers to examine its effects on Selank: The Tuftsin Analogue and Its Role in Neuroprotection without the molecule vanishing immediately.
Once introduced into a preclinical model, Selank interacts directly with the GABAergic system. Gamma-aminobutyric acid, or GABA, acts as the main brake pedal in the nervous system. When stress signals fire too rapidly, neural circuits become noisy and scattered, making focus difficult. Published studies show that Selank gently adjusts how GABA receptors bind to their natural messengers. Unlike harsh sedatives that slam the brakes and cause heavy drowsiness, Selank acts as an allosteric modulator. It helps the receptor respond more smoothly to natural GABA without forcing the channel open on its own, which explains why laboratory models show reduced stress behaviour alongside clear, alert wakefulness.
At the same time, Selank protects natural enkephalins—tiny internal peptides that regulate mood and stress responses—by slowing down the enzymes that normally chew them up. Keeping enkephalin levels steady prevents the nervous system from spiralling into high-alert fatigue. Alongside this calming action, Selank stimulates the expression of Brain-Derived Neurotrophic Factor, known simply as BDNF. Think of BDNF as structural fertiliser for neurons. It supports synaptic plasticity, helps existing brain cells repair daily wear and tear, and encourages new connections to form during learning tasks. By combining calm GABA signalling with a steady rise in BDNF, Selank creates an internal environment where neural tissue can recover from stress while staying mentally sharp.

Selank
From £16
Supplied as a sealed freeze-dried vial (stable 12–24 months at 2°C–8°C in a standard refrigerator).
Shop Selank →What Published Studies Measure Across Different Timeframes
When scientists investigate Selank in laboratory models, they divide their observations into immediate chemical shifts and slower, long-term structural changes. Because the peptide is small and carries that protective Proline-Glycine-Proline tail, its initial signalling begins remarkably fast, often within the first fifteen to thirty minutes of a study protocol. During this early window, researchers track immediate changes in neurotransmitter turnover and gene expression across brain regions linked to stress and memory, particularly the hippocampus and frontal cortex.
Within the first few hours of a measured level being introduced into a preclinical model, published studies record a rapid adjustment in mRNA transcripts for dozens of genes tied to neurotransmission. Specifically, researchers observe a quick rise in BDNF mRNA expression, sometimes doubling compared to baseline control groups within three to twenty-four hours. Alongside this early genetic signalling, blood and tissue assays in animal models show a swift drop in stress-induced serotonin metabolites and a stabilization of dopamine and norepinephrine ratios. This early phase is all about calming electrical noise and stopping stress hormones from overwhelming delicate neural circuits.
Moving past the first forty-eight hours into multi-day or multi-week study timelines, the focus shifts from fast chemical signalling to physical tissue remodelling and sustained behavioural recovery. In published studies running across seven to fourteen days, researchers evaluate how daily or repeated protocol ratios influence memory retention, learning speed, and resilience against chronic stress conditions. During this second week, the early spikes in BDNF translate into measurable structural benefits, such as improved synaptic density and healthier dendritic branching in hippocampal tissue samples.
Furthermore, long-term preclinical models examining immune-neural cross-talk over fourteen to twenty-one days highlight Selank's heritage as a tuftsin analogue. Over these extended timelines, laboratory models demonstrate balanced cytokine profiles, notably steadying interleukin-6 (IL-6) levels that otherwise spike during prolonged environmental stress. By keeping neuroinflammation in check week after week, the peptide prevents the slow structural wear that chronic stress inflicts on memory centres. Whether a study looks at a thirty-minute receptor shift or a three-week recovery curve, the timeline shows a clear handoff from fast neurotransmitter balance to lasting neural protection.
Molecular Comparison: Selank vs. Related Research Peptides
| Feature | Selank | Native Tuftsin | Semax |
|---|---|---|---|
| Amino Acid Sequence | Thr-Lys-Pro-Arg-Pro-Gly-Pro (7 amino acids) | Thr-Lys-Pro-Arg (4 amino acids) | Met-Glu-His-Phe-Pro-Gly-Pro (7 amino acids) |
| Structural Origin | Synthetic tuftsin analogue with a Pro-Gly-Pro C-terminal tail | Endogenous fragment of the immunoglobulin G (IgG) heavy chain | Synthetic fragment of adrenocorticotropic hormone (ACTH 4-10) with a Pro-Gly-Pro tail |
| Primary Laboratory Focus | GABAergic modulation, enkephalinase inhibition, and neuroprotection | Phagocytosis stimulation and innate immune cell signalling | Melanocortin receptor interaction, BDNF upregulation, and cognitive focus models |
| Enzymatic Stability | Extended stability in vitro due to the protective Pro-Gly-Pro tripeptide sequence | Rapidly degraded by tissue peptidases within a few minutes | High resistance to enzymatic breakdown due to the C-terminal Pro-Gly-Pro motif |
| Key Signalling Pathways | GABA-A receptor allosteric binding, BDNF expression, and serotonin metabolism | Neuropilin-1 and tuftsin receptor pathways on macrophages and microglia | TrkB receptor signalling, dopaminergic, and serotonergic system modulation |
Pairing Selank with Complementary Neuropeptide Stacks
Researchers exploring cognitive research peptides rarely view neural signalling in isolation, which is why Selank is frequently paired with complementary compounds in multi-peptide study designs. Because Selank focuses primarily on calming GABAergic tone, protecting enkephalins, and regulating immune cytokines, it pairs naturally with peptides that target energy production, blood flow, or deeper structural tissue repair.
The most famous pairing in published Russian and Eastern European literature combines Selank with Semax. While Selank is built from an immune fragment to promote calm focus and steady emotional tone, Semax is derived from a tiny fragment of ACTH (adrenocorticotropic hormone) designed to drive mental stamina, attention, and strong neurotrophic output. Both peptides share the exact same Proline-Glycine-Proline (PGP) protective tail at their C-terminus. When researchers evaluate them together—often using Selank during the quieter recovery phase of a protocol and Semax during high-demand learning tasks—they observe complementary support for BDNF and nerve growth factor (NGF) without overstimulating the model.
Beyond purely neural combinations, investigators also examine how central nervous system calm interacts with peripheral tissue regeneration. Stress signalling in the brain directly slows down physical repair throughout the rest of the body by keeping cortisol high and restricting blood flow. Consequently, pairing Selank alongside systemic recovery blends such as bpc157 and tb500 offers a broader way to study whole-system recovery. While BPC-157 and TB-500 work locally on angiogenesis, actin upregulation, and fibroblast migration in tendons or gut tissue, Selank keeps central stress signalling quiet so systemic inflammation stays low.
Another area of interest involves pairing Selank with mitochondrial or circadian regulators like Epitalon or Pinealon. Because high oxidative stress in the brain drains cellular energy and disrupts sleep-wake cycles in preclinical models, combining a GABA-modulating peptide like Selank with short bioregulator tripeptides allows scientists to observe how calm daytime signalling supports deeper nighttime cellular maintenance. Across all of these combinations, the goal remains simple: pair molecules that work on separate, non-overlapping receptors so their benefits stack cleanly without overwhelming any single biological pathway.

Figure: Selank: The Tuftsin Analogue and Its Role in Neuroprotection
Reconstitution calculator
Choose a vial mass and a bacteriostatic reconstitution solution volume. The figure is the resulting concentration.
Concentration: 2.50 mg/mL
Per 0.01mL (10µL): 25.0 mcg
Open the full calculatorBacteriostatic reconstitution solutionWhy Analytical Purity and Cold Storage Matter for Selank
Working with a delicate heptapeptide like Selank requires strict attention to how the molecule is synthesised, purified, and stored before any laboratory work begins. Selank consists of the exact seven-amino-acid sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro. During solid-phase peptide synthesis, chemists link these amino acids together one step at a time. If even a single coupling step falls slightly short, the batch ends up contaminated with truncated sequences—five- or six-amino-acid fragments that look similar on paper but fail to bind properly to GABA receptors or trigger BDNF expression in a dish.
To prevent truncated fragments from ruining an experiment, reputable suppliers verify every batch using High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry (MS), aiming for a verified purity level above 99%. Just as important as the peptide sequence itself is the removal of Trifluoroacetic Acid, or TFA. TFA is a harsh solvent routinely used to cleave peptides from their resin during manufacturing. If residual TFA salts are left behind in the final lyophilised powder, they lower the pH of the solution and can damage fragile neural cell cultures on contact. High-grade Selank undergoes an extra ion-exchange step to swap out toxic TFA ions for benign acetate salts, keeping the vial clean and predictable for sensitive assays.
Once a high-purity lyophilised puck arrives in the laboratory, proper thermal storage keeps the seven-amino-acid chain intact. In its freeze-dried powder form, Selank is stable for short shipping transits, but it should be placed straight into a refrigerator set between 2°C and 8°C (or frozen at -20°C for long-term archiving) away from bright light. When preparing the peptide for an assay using a sterile bacteriostatic reconstitution solution, liquid should be trickled slowly down the inside glass wall of the vial rather than blasted directly onto the powder.
Never shake a reconstituted vial of Selank; gentle swirling lets the peptide dissolve completely without shearing the bonds. Once mixed into liquid form, the vial must stay refrigerated at 2°C to 8°C at all times and be kept away from repeated freeze-thaw cycles. By demanding 99%+ HPLC purity, acetate salt conversion, and strict cold-chain storage, researchers ensure their observations reflect Selank itself rather than degraded byproducts.
Frequently Asked Questions
Why is Selank: The Tuftsin Analogue and Its Role in Neuroprotection widely researched?
Researchers investigate Selank because this synthetic tuftsin analogue demonstrates notable neuroprotective properties in laboratory models. Published studies show it influences GABAergic signalling and modulates brain-derived neurotrophic factor levels. Scientists analyse these specific pathways to understand how the seven-amino-acid peptide supports cellular resilience and neural recovery during periods of simulated stress.
What is the typical timeline observed in Selank laboratory studies?
In preclinical models, shifts in gene expression and neurotransmitter signalling often appear within a few hours of exposure. Extended published studies typically track neural tissue remodelling and behavioural markers over ten to fourteen days. Researchers monitor these specific windows to characterise both immediate signalling changes and longer-term neuroprotective outcomes.
Can Selank be combined with other peptides in research protocols?
Yes, laboratory protocols frequently pair Selank with Semax to observe combined effects on neural signalling pathways. Because Selank derives from tuftsin and Semax originates from an ACTH fragment, researchers analyse how the two peptides interact simultaneously. Published studies indicate this combination helps scientists map distinct yet complementary mechanisms of neuroprotection.
How should Selank be stored to maintain purity in the laboratory?
Lyophilised Selank should be stored in a laboratory freezer at minus twenty degrees Celsius to preserve its structural integrity. Once mixed with a bacteriostatic reconstitution solution, the liquid peptide must stay refrigerated between two and eight degrees Celsius. Always verify batch purity above ninety-eight percent using high-performance liquid chromatography certificates.
Bibliography
- Volkova, A., et al. (2016). Selank Administration Affects the Expression of Some Genes Involved in GABAergic Neurotransmission. Frontiers in Pharmacology, 7, 31. View published research
- Inozemtseva, L. S., et al. (2008). Intranasal administration of the peptide Selank regulates BDNF expression in the rat hippocampus in vivo. Doklady Biological Sciences, 421, 241-243. View published research
- Kost, N. V., et al. (2001). Semax and selank inhibit the enkephalin-degrading enzymes of human serum. Bioorganicheskaia Khimiia, 27(3), 180-183. View published research
- Kolomin, T., et al. (2014). The Temporary Dynamics of Inflammation-Related Genes Expression under Tuftsin Analog Selank Action. Molecular Immunology, 58(1), 50-55. View published research
- Semenova, T. P., et al. (2009). Optimization of learning and memory processes by selank in rats with experimentally induced blockade of the serotoninergic system. Bulletin of Experimental Biology and compound, 147(6), 691-693. View published research
⚠️ Research Use Only Disclaimer: All peptides and compounds are sold strictly for in-vitro laboratory research purposes only. Not intended for human or veterinary use, not a dietary supplement, and not approved to diagnose, treat, cure, or prevent any disease or condition. For use by qualified researchers in suitably equipped laboratory environments only. Amino Peptides Ltd operates in full compliance with UK MHRA regulations and applicable EU research chemical guidelines.